ＩＣＯＳに対する抗体 - Johns Therapeutics, Incorporated

Title:

ＩＣＯＳに対する抗体

Document Type and Number:

Japanese Patent JP6944924

Kind Code:

B2

Abstract:

Provided herein are various embodiments relating to antibodies. Some of the embodiments include agonist antibodies that bind ICOS. Such antibodies can be used in methods to treat, for example, cancer.

More Like This:

WO/2005/023872	ANTIBODIES AGAINST INTERLEUKIN-1 RECEPTOR AND USES THEREOF
JP2022528820	Antibodies and compositions for use in the detection or capture of polypeptides in a sample, and methods for the detection or capture of polypeptides in a sample.
JP2022541349	Antigen-binding protein that specifically binds to MAGE-A

Inventors:

Stephen Saddinski
Michelson, Jennifer S.
Satya Narayanan, Sri Ram
Erpek, Cthuljeksu

Application Number:

JP2018501142A

Publication Date:

October 06, 2021

Filing Date:

March 22, 2016

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Johns Therapeutics, Incorporated

International Classes:

C12N15/13; A61K39/395; A61P35/00; C07K16/28; C07K16/46; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/63; C12P21/08

Domestic Patent References:

JP2014511843A
JP2010527585A

Other References:

PE anti-human/mouse/rat CD278(ICOS) Antibody, BioLegend, Inc. 2013, p. 1, Retrieved from the Internet: on 2020.02.27

Attorney, Agent or Firm:

Sonoda/Kobayashi Patent Business Corporation

Previous Patent: 情報処理プログラム、情報処理装置、情報処理システム、および、情報処�...

Next Patent: 組織浸潤ＮＫ細胞を検出する方法